“…Disruption of the calcium homeostasis by pharmacological agents or pathological conditions correlate with various conditions, including prolonged QT intervals and arrhythmias in the heart 2 3 , or ischemic kidney injuries resulting in poor outcome for kidney transplantations 4 . In fact, several drugs with various mechanisms of action had to be withdrawn from the market because of side effects caused by disruption of the calcium homeostasis, including Clobutinol, a cough suppressant 5 , Dofetilide, an antiarrhythmic agent 6 , Grepafloxacin and Sparfloxacin, antibacterial agents 7 , Terfenadine, an antihistamine 8 , or Terodiline, a spasmolytic agent 9 . All these findings suggest that in the process of drug discovery an early prediction of toxicity requires the direct examination of the drug effects on cellular calcium homeostasis and signaling in different target tissues, especially in the heart.…”